桃红四物汤对激素性股骨头缺血性坏死bFGF表达及微循环影响的实验研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:通过观察桃红四物汤对激素性股骨头缺血性坏死碱性成纤维细胞生长因子(basic fibroblast growth factor bFGF)表达的影响,同时对比研究桃红四物汤对激素性股骨头缺血性坏死模型兔股骨头局部微血管密度和血液流变学的影响,进一步阐明活血化瘀法对激素性股骨头缺血性坏死的防治机理,为该方法的临床推广应用提供理论依据。
     方法:60只健康成年新西兰大白兔,首先随机分为两组:正常组6只和实验组54只,实验组每周2次臀肌注射醋酸氢化泼尼松7.5mg/kg,经6周诱导出激素性股骨头缺血性坏死的早期模型;正常组每周2次臀肌注射同等剂量的生理盐水。6周后处死正常组6只和实验组6只,进行电镜观察,确定造模成功;将剩余实验动物随机分为中药治疗组和激素对照组:中药治疗组以桃红四物汤7ml/kg治疗,一日一次,激素对照组以生理盐水7ml/kg治疗,一日一次。并分别于治疗后第1、2、4周全部处死取材。进行组织病理观察、血液流变学、血清bFGF含量和股骨头局部微血管密度的检测。
     结果:①电镜观察:实验组骨细胞数量减少,退变固缩或出现脂滴,成骨细胞减少,髓内脂肪细胞增大,正常组骨细胞富含粗面内质网,多聚核糖体多,线粒体发达,嵴结构清晰,核异染色质丰富,核仁可见。②组织病理学观察:激素对照组空缺骨陷窝数明显增多,骨小梁稀疏,髓腔脂肪细胞增大、增多;中药治疗组空缺骨陷窝数减少,骨小梁增多、增密。③血液流变学检测:激素对照组全血高切和低切粘度、血浆粘度、红细胞压积、纤维蛋白原含量等明显高于中药治疗组,并且,随着中药治疗时间的延长,中药治疗组血液流变学趋于正常,与激素对照组的差异更明显。④放射免疫检测血清bFGF的表达:中药治疗组bFGF的表达增强,与激素对照组相比有明显差异(p<0.01)。⑤免疫组化检测股骨头局部血管密度的改变:中药治疗组股骨头局部血管密度逐渐增高,激素对照组股骨头局部微血管密度较中药治疗组明显减低。
     结论:短期内大剂量使用激素,可以引起股骨头缺血性坏死,实验动物股骨头局部骨组织、骨细胞发生异常改变,血液流变学异常。桃红四物汤的使用可使激素性股骨头缺血性坏死模型兔bFGF的表达增强,从而可以有效促进微血管的再生,增加局部微血管密度;同时,桃红四物汤可明显纠正激素性股骨头缺血性坏死模型动物血液流变学异常,降低血液粘稠度,改善局部微循环障碍状态,促进激素性股骨头缺血性坏死的修复,这可能是活血化瘀法防治该病的机理之一。
Purpose: To investigate the effect on basic fibroblast growth factor、microvessel density and hemorheology of glucocorticoid-induced avascularnecrosis of femoral head in rabbits by treatment of tap hong si wu decoction. Tointerpret the mechanism of the effect on glucocorticoid-induced avascularnecrosis of femoral head by activating blood circulation, and offer a effectivemethod to clinical.
     Method: 60 rabbits were randomly divided into 2 groups: 6 rabbits were in commongroup and 54 rabbits were in experimental group, the rabbits in common groupwere as normal control; the rabbits in experimental group were administered withhydroxyprednisone through gluteus injection (twice a week) for 6 weeks as control: there were 6 rabbits were killed in each group after 6 weeks, to be assure thatthe model were succed. All surplus rabbits were divided into healing group andcontrol group: the healing group were administrated with tap hong si wu decoction7ml/kg per day, the control group were administrated with sodium chloride 7ml/kgper day. then, after 1、2 and 4 weeks, killed the animal, and detected all indexes.
     Results:①the result electron microscope showed: in the experiment group, bonecell decreased, cataplasised and pyknosised, lipid droplet emerged, the numberof osteoblast decreased, adipocytes in the camera pulpi accreted, bone cells inthe common group contained large number of rough endoplasmic reticulum andpolysome, bioblast becameprosperous, the architecture of the crista was lampros, kernel heterochromatin were plentiful, nucleolus could be seen.②histomorphologic measurements showed that empty lacuna increased and trabeculaof bone decreased more significantly in control groups and than those in healing group and the medullary cavity lipocytes in control group showed larger sizeand more amount than those in healing group.③whole blood viscosity, plasmaviscosity and fibrin in control groups increased significantly compared withthose in healing groups.④the expression of bFGF in serum measured byradioimmunity reinforced significantly in healing groups compared with controlgroups.⑤microvessel density(MVD) detected by immunohistochemistry: the MVD offemoral head in healing groups increased day by day, the MVD of femoral headin control groups degraded significantly compared with healing groups.
     Conclusion: The administration of large dose glucocorticoid can induced avacularnecrosis of femoral head. the bone tissue and the bone cell of the femoral headand the hemorheology were changed abnormality, the condition could be improvedand the expression of bFGF could be reinforced by tap hong si wu decoction, atthe same time, it facilited the regeneration of capillary vessel and improvedthe condition of microcirculation, maybe that was one reason why tap hong si wudecoction effect on glucocorticoid-induced avacular necrosis of femoral head.
引文
[1] 胥少汀,葛宝丰,徐印坎.实用骨科学[M].第三版,人民军医出版社,2005:1822.
    [2] 齐振熙,曹阳.不同治法防治激素性股骨头缺血性坏死的实验研究[J].中国骨伤,2002,15(2):77-78.
    [3] 贺西京,毛履真,王坤正等.肾上腺糖皮质激素引起股骨头缺血性坏死的机制实验研究[J].中华骨科杂志,1992,12(6):440-442.
    [4] Arlet J. Nontraumatic avascular necrosis of the femoral head: past, present, and future[J]. Clin Orthop, 1992, 277:12-16.
    [5] Hungerford DS. Pathogenetic considerations in ischemic necrosis of bone[J]. The Canadian Journal of Surgery, 1981, 24:583.
    [6] Thomas J. Cortison-induced alteration in lipid metabolism[J]. Archives Pathology, 1962, 73:53.
    [7] Wang GJ. Fat-cell changes as a mechanism of avascular necrosis on the femoral head in cortisone-treated rabbits[J]. J Bone Joint Surg (Am), 1977, 59:729.
    [8] David S, Thomas. Pathogenesis of ischemic necrosis of the femoral head[J]. J Bone Joint Surg(Br):1964, 46:270.
    [9] Kawai K, Maruno H. Fat necrosis of osteocytes as a causative factor in idiopathic osteonecrosis in heritable hyperlipaemic rabbits[J]. Clin Orthop, 1980, 153:273.
    [10] Jones JP. Intravascular coagulation and osteonecrosis[J]. Clin Orthop, 1992, 277:41-53.
    [11] Jones JP. Fat embolism, intravascular coagulation and osteonecrosis[J]. Clin Orthop, 1993, 292:294-308.
    [12] Jones JP Jr. Coagulopathies and Osteonecrosis[J]. Acta Orthop Belg, 1999, 65(Suppl1):5-11.
    [13] Arlet J. Nontraumatic avascular necrosis of the femoral head: past, present, and future[J]. Olin Orthop, 1992, 277:12-16.
    [14] Satio, s. kenjiOhozono, Keiroono. Early Arteriopathy and postulated pathogenesis of osteonecrosis of femoral head. Clin orthop, 1992, 277:98-110.
    [15] Masuhara M. Yasunaga M. Tanigawa K. etc. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatol ogy. 1996, Aug; 24(2):323-9.
    [16] Caffey J. Paper A. Avascular necrosis:early MR imaging and histologic findings in acanine model. AJR. 1991, 157:341-345.
    [17] 田牛.实用临床微循环学(上册)(M).北京:军事科学出版社,1989:28-31.
    [18] 朱建红.中医对微循环的若干认识[J].微循环学杂志,2002,12(2):41—43.
    [19] 徐传毅,黄涛,邹季等.从血瘀证论治激素性股骨头坏死的实验研究[J].中国中医骨伤科杂志.2000,8(4):10-13.
    [20] 赵宁侠.艾灸三阴交对健康人血液流变学及红细胞聚集指数的影响[J].云南中医学院学报.2003,26(4):32.
    [21] 史风雷,任丽霞,孙升云等.复方丹参注射液预防激素性股骨头坏死的初步研究[J].中医正骨,2000,14(4):3-5.
    [22] 刘剑刚,史大卓.影响血液流变学的活血化瘀中药药物研究[J].中国血液流变学杂志,2004,14 (1):133—137.
    [23] 翁维良、王怡、刘剑刚等.三十四种活血化瘀药的研究[A].中国中西医结合学会活血化瘀专业委员会血瘀证与活血化瘀研究.北京:学苑出版社,1996,180-183.
    [24] 陈可冀,张之南,梁之钧等.血瘀证与活血化瘀研究[M].上海科学技术出版社,1990:429-497.
    [25] 许旭伟,何立人,张秋娟等.bFGF在高龄急性脑梗死小鼠大脑皮层内的表达及祛瘀生新中草药对其的影响[J].江西中医学院学报,2004,16(3):58-60.
    [26] 孙劲松,奚九一,胡伟奇等.清脉791-2冲剂对肢体血管闭塞大鼠促血管生成作用的实验研究[J].北京中医药大学学报,2006,29(5):328-331.
    [27] 刘军,吴卫平,匡培根等.丹参在缺血再灌注时的神经保护作用——成纤维细胞生长因子上调[J].中国神经免疫学和神经病学杂志,1993,3(4):225-229.
    [28] 高冬、宋军、胡娟等.活血化瘀中药对鸡胚绒毛尿囊膜血管生成的影响[J].中国中西医结合杂志,2005,25(10):912-915.
    [29] Gospodarowiez D. Fibroblast growth factor[J]. Clin Orthop, 1990, 257: 231.
    [30] Falkman J. Tumor angiogensis[J]. Adv Cancer Res, 1985, 43:175-203.
    [31] Aspenberg P, Lohmander LS. Fibroblast growth factor stimulates bone formation. Bone induction studied in rats. Acta Orthop Scand, 1989, 60(4): 473—476.
    [32] Wang JS. Basic fibroblast growth factor for stimulation of bone formation inostcoin duction or conductive implants[J]. Acta Orthop Scand, 1996, (Supple 269), 67:1-32.
    [33] 于德新,王滨,于钦森等.肝细胞癌CT增强特征与bFGF表达和血管生成关系探讨[J].实用放射学杂志,2005,21(1):5-8.
    [34] 吕菁君,林国生,李庚山.骨髓单个核细胞自体移植促进心脏血管再生[J].中华胸心血管外科杂志,2004,20(2):102-104.
    [35] 张从纪,李慧增,周树夏等.颌面部爆炸伤愈合过程中血管相关生长因子变化和作用的实验研究[J].中华创伤杂志,2000,16(1):35-37.
    [36] 李丹阳,赵葵,陈鹏.碱性成纤维细胞生长因子、腺苷对兔急性心肌梗死后血管再生的影响[J].中华急诊医学杂志,2004,13(1):27-29.
    [37] 鲁晓波,郝建伟,王兆强.皮瓣缺血训练后碱性成纤维细胞生长因子及微血管密度的变化[J].中华显微外科杂志,2006,29(1):48-50.
    [38] 朱华锋,汪春兰,赵宇等.应用碱性成纤维细胞生长因子基因治疗促进大鼠早期断蒂皮瓣的成活[J].安徽医科大学学报,2006,41(4):386-388.
    [39] 张晓刚,邓沂,王钢,等.中医药治疗股骨头坏死回顾与理方研究[J].甘肃中医学院学报,1999,16(3):7—8.
    [40] 史风雷,任丽霞,孙升云等.复方丹参注射液预防激素性股骨头坏死的初步研究[J].中医正骨,2000,14(4):3-5.
    [41] 刘宏泽.王文瑞.卫小春等.丹参与骨碎补注射液防治激素诱发股骨头坏死的实验研究[J].中医正骨,2003,16(12):726-728.
    [42] 谭儒民,刘瑞新,尹冬梅等.股骨头髓心减压配合活血化瘀中药治疗股骨头坏死[J].中国中医骨伤科杂志,2005,13(1):42.
    [43] 靳玉良.姜颖韶.朱强.中药内服外敷治疗股骨头缺血性坏死198例[J].辽宁中医杂志,2005,32(1):53—54.
    [44] 涂明中,游卫华,陈立.等.血管介入加活血中药灌注治疗股骨头缺血性坏死23例[J].中国中西医结合外科杂志,2005,11(3):223—224.
    [45] Mont MA, Jones LC, Einhorn TA, et. Osteonecrosis of the femoral head potential treatment with growth and differentiation factors[J]. Clin Orthop, 1998, 355(suppl):314-335.
    [46] McCarthy TL, Centrella M, Canalis E. Effects of fibroblast growth factors on deoxyrib onucileic acid and collagen synthesis in rat parietal bone cells. Endocrinology, 1989, 125(4):2118-26.
    [47] 车建伟,张卫平,刘建等.重组合异种骨复合bFGF对兔股骨头坏死修复的影响[J].临床误诊误治,2006,19(6):45-47.
    [48] 龚跃昆,彭吾训,李彪等.bFGF/BMP/AACB复合物修复犬股骨头缺损坏死模型的实验研究.中华创伤骨科杂志,2006,8(3):248-251.
    [49] 郑启新,郭晓东,刘勇等.bFGF基因修饰的间充质干细胞/多孔β-TCP陶瓷复合移植修复兔节段性骨缺损[J].中国生物医学工程学报,2003,22(2):171-177.
    [50] 杨操,杨述华,杜靖远等.bFGF基因转染促进股骨头坏死修复的实验研究[J].中国矫形外科杂志,2004,12(16):1236-1239.
    [51] 李晓辉,宋跃明,李世和等.碱性成纤维细胞生长因子复合部分脱蛋白骨修复兔股骨头骨缺损的作用机理及相关性分析[J].中国矫形外科杂志,2005,13(13):1010-1014.
    [52] 李晓辉,龚跃昆,宋跃明等.碱性成纤维细胞生长因子复合部分脱蛋白骨增强兔股骨头骨缺损修复作用的研究[J].中国修复重建外科杂志,2005,19(3):183-186.
    [53] 周华江,聂林,张琦等.碱性成纤维细胞生长因子对兔股骨头坏死模型实验修复过程的影响[J].中国矫形外科杂志,2002,10(9):895-897.
    [54] 靳松,沈靖南,王晋等.碱性成纤维细胞因子和骨形态发生蛋白对股骨头坏死修复过程的研究[J].中华实验外科杂志,2006,23(9):1142.
    [55] 史有志,潘振国,矫德欣等.重组合异种骨植入、留管介入碱性成纤维细胞生长因子 股骨头缺血性坏死[J].中国临床康复,2003,7(32):4416.
    [1] Jaye M, Schlessinger J, Craig A, et al. FGFG tyrosine kinases moolecular analysis and signal transduction[J]. Biochem Acta, 1992, 1135:185-199.
    [2] Brighton CT, Principles of fracture healing. In:cornell CN, LaneJM. Newest factors in fracture healing[J]. Clin Orthop, 1992, 277:297-312.
    [3] Kotev-Emeth S, Savion N. Effect of maturation on the osterogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor[J]. Bone, 2000, 27(6):777-783.
    [4] Niswandr L, Martin G, FGF4 and BMP have opposite effects on limb growth[J]. Nature, 1993, 361:68-71.
    [5] Lind M. Growth factors;possible new clinical tools[J]. A review Acta Orthop Scand, 1996, 67(4):407-417.
    [6] Fukuda A, Kato K, Hasegawa M, et al. Enhanced repair of large osteochondral defects us ing a combination of artificial cartilage and basic fibroblast growth factor[J]. Biomaterials. 2005, 26(20):4301-8.
    [7] Duan H, fan H, Chen J, et al. Experimental studies on exterior bFGF for enhancement of membrane guided bone regeneration[J]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004, 21(6):879-83.
    [8] Hisatome T, Yasunaga Y, Yanada S, et al. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells[J]. Biomaterials. 2005, 25(22):4550-6.
    [9] 段宏,王光林,裴福兴等。碱性成纤维细胞生长因子缓释微球对成骨细胞作用的实验研究[J]。中华创伤杂志。2004,20(2):89-92。
    [10] Zuo J, Jiang J, Dolce C, et al. Effects of basic fibroblast growth factor on osteocl asts and osteoclast-like cells[J].Biochem Biophys Res Commun. 2004,318(1):162-7.
    [11] Li X, Gong Y, Song Y, Li S, et al. Study on the effect of composite of basic fibrobla st growth factor and partially deproteinized bone on the repair of femoral head de fects[J]. Zhong Guo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005, 19(3):183-6.
    [12] Yan C, Yang SH, DU JY, et al. Basic fibroblast growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head[J]. Chin Med Sci. 2004, 19(2):111-5.
    [13] 齐振熙,曹阳。不同治法防治激素性股骨头缺血坏死的实验室研究[J]。中国骨伤,2002,15(2):77-78。
    [14] 杨操、杨述华、杜靖远等,bFGF基因转染促进骨骨头坏死修复的实验研究[[J]。中国矫形外科杂志。2004,12(16):1236-1239。